Editorial: The regulatory role of metabolic organ-secreted factors in the development of cardiovascular diseases

Mei You; Cheng-Chao Ruan; Qiuhua Yang; James Philip Hobkirk; Peng Gao

doi:10.3389/fcvm.2023.1246912

Editorial: The regulatory role of metabolic organ-secreted factors in the development of cardiovascular diseases

Front Cardiovasc Med. 2023 Jul 13:10:1246912. doi: 10.3389/fcvm.2023.1246912. eCollection 2023.

Authors

Mei You¹, Cheng-Chao Ruan², Qiuhua Yang³, James Philip Hobkirk⁴, Peng Gao¹

Affiliations

¹ Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Chongqing Institute of Hypertension, Army Medical University, Chongqing, China.
² State Key Laboratory of Medical Neurobiology, Shanghai Key Laboratory of Bioactive Small Molecules, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
³ Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.
⁴ School of Life Sciences, University of Hull, Kingston upon Hull, United Kingdom.

No abstract available

Keywords: cardiac hypertrophy; cardiovascular disease; metabolic organ-secreted factor; myocardial infarction; nonalcoholic fatty liver disease.

Publication types

Editorial

Grants and funding

This work was supported by the National Natural Science Foundation of China (grant numbers 82022006 and 82270440) and Natural Science Foundation of Chongqing (cstc2021jcyj-jqX0002).